Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS)

Does nebivolol reduce mortality and cardiovascular hospital admission in elderly patients with heart failure?

Population

Elderly patients with heart failure

Intervention

Nebivolol

Outcome

Mortality and cardiovascular hospital admissioncomposite

Nebivolol is an effective and well-tolerated treatment for heart failure in elderly patients.

Nebivolol, a beta-blocker with vasodilating properties, is an effective and well-tolerated treatment for heart failure in the elderly.

Bookmark

View Full Paper

Cite This Study

Flather et al. (Sun,) studied this question.

Bookmark

View Full Paper